The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-7771
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers ; volume:10 ; number:1 ; day:8 ; month:10 ; year:2022 ; pages:1-25 ; date:12.2022
Biomarker Research ; 10, Heft 1 (8.10.2022), 1-25, 12.2022
- Creator
-
Yu, Ya-ya
Zhu, Yan-juan
Xiao, Zhen-zhen
Chen, Ya-dong
Chang, Xue-song
Liu, Yi-hong
Tang, Qing
Zhang, Hai-bo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-022-00421-0
- URN
-
urn:nbn:de:101:1-2022122621331844856897
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yu, Ya-ya
- Zhu, Yan-juan
- Xiao, Zhen-zhen
- Chen, Ya-dong
- Chang, Xue-song
- Liu, Yi-hong
- Tang, Qing
- Zhang, Hai-bo
- SpringerLink (Online service)
Other Objects (12)
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
Organoid technology for personalized pancreatic cancer therapy
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Organoid based personalized medicine: from bench to bedside
A Promising New Model: Establishment of Patient‐Derived Organoid Models Covering HPV‐Related Cervical Pre‐Cancerous Lesions and Their Cancers
Organoid modeling meets cancers of female reproductive tract
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
The application of patient-derived organoid in the research of lung cancer
Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
Organoid technology for personalized pancreatic cancer therapy
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Organoid based personalized medicine: from bench to bedside
A Promising New Model: Establishment of Patient‐Derived Organoid Models Covering HPV‐Related Cervical Pre‐Cancerous Lesions and Their Cancers
Organoid modeling meets cancers of female reproductive tract
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
The application of patient-derived organoid in the research of lung cancer
Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
Organoid technology for personalized pancreatic cancer therapy
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Organoid based personalized medicine: from bench to bedside
A Promising New Model: Establishment of Patient‐Derived Organoid Models Covering HPV‐Related Cervical Pre‐Cancerous Lesions and Their Cancers
Organoid modeling meets cancers of female reproductive tract
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold
The application of patient-derived organoid in the research of lung cancer
Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer